Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 23 matching records.
23 results — page 1 of 1
- Level BClinical TrialPubMed
Clinical efficacy and safety of allogeneic adipose-derived stem cells ELIXCYTE in chronic kidney disease: a phase I/II study.
Clinical Trial on Chronic Kidney Disease, published in Stem Cells Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cells Transl Med - Level BClinical TrialPubMed
Preclinical safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell medicinal product for rotator cuff repair: a two-phase experimental study.
Clinical Trial with a reported sample of 24 on Tendon Injury, Rotator Cuff, published in J Shoulder Elbow Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 24
J Shoulder Elbow Surg - Level ASystematic ReviewPubMed
Clinical Safety and Efficacy of Allogeneic Adipose Stem Cells: A Systematic Review of the Clinical Trials.
Systematic Review with a reported sample of 953 on Osteoarthritis, Chronic Kidney Disease, Scar, Autoimmune Research, published in Int J Mol Sci (2025) — summary generated from the PubMed abstract.
- 2025
- n = 953
Int J Mol Sci2 citations - Level BClinical TrialPubMed
Safety and efficacy of long-shelf-life allogeneic adipose-derived mesenchymal stem cell line-derived platelet-like cells for refractory foot ulcers: A translational preclinical and phase 1/2a study.
Clinical Trial on Chronic Wound, published in Regen Ther (2025) — summary generated from the PubMed abstract.
- 2025
Regen Ther - Level BClinical TrialPubMed
Efficacy and safety of autologous or allogeneic mesenchymal stromal cells from adult adipose tissue expanded and combined with tricalcium phosphate biomaterial for the surgical treatment of atrophic nonunion of long bone
Clinical Trial with a reported sample of 14, published in J Transl Med (2024) — summary generated from the PubMed abstract.
- 2024
- n = 14
J Transl Med10 citations - Level BRandomized Controlled TrialPubMed
Safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell preparation in the treatment of knee osteoarthritis: A Phase I/IIa randomised controlled trial.
Randomized Controlled Trial with a reported sample of 40 on Knee Osteoarthritis, Osteoarthritis, published in Osteoarthr Cartil Open (2024) — summary generated from the PubMed abstract.
- 2024
- n = 40
Osteoarthr Cartil Open10 citations - Level BRandomized Controlled TrialPubMed
Safety and therapeutic potential of allogeneic adipose-derived stem cell spray transplantation in ischemic cardiomyopathy: a phase I clinical trial.
Randomized Controlled Trial with a reported sample of 3 on Cardiovascular Disease, published in J Transl Med (2024) — summary generated from the PubMed abstract.
- 2024
- n = 3
J Transl Med7 citations - Level BRandomized Controlled TrialPubMed
Local, systemic and immunologic safety comparison between xenogeneic equine umbilical cord mesenchymal stem cells, allogeneic canine adipose mesenchymal stem cells and placebo: a randomized controlled trial.
Randomized Controlled Trial on Systemic / IV, published in Front Vet Sci (2023) — summary generated from the PubMed abstract.
- 2023
Front Vet Sci3 citations - Level CProspective StudyPubMed
Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Prospective Study on Scar, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cell Res Ther9 citations - Level BClinical TrialPubMed
Allogeneic adipose tissue-derived stem cells ELIXCYTE ® in chronic kidney disease: A phase I study assessing safety and clinical feasibility.
Clinical Trial with a reported sample of 12 on Chronic Kidney Disease, published in J Cell Mol Med (2022) — summary generated from the PubMed abstract.
- 2022
- n = 12
J Cell Mol Med12 citations - Level BClinical TrialPubMed
Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Complex Perianal Fistulas Not Associated With Crohn's Disease: A Phase I Clinical Trial.
Clinical Trial with a reported sample of 20 on Autoimmune Research, published in Dis Colon Rectum (2021) — summary generated from the PubMed abstract.
- 2021
- n = 20
Dis Colon Rectum - Level BRandomized Controlled TrialPubMed
Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: s
Randomized Controlled Trial with a reported sample of 30 on Type 2 Diabetes, Peripheral Artery Disease, published in Trials (2021) — summary generated from the PubMed abstract.
- 2021
- n = 30
Trials10 citations - Level BClinical TrialPubMed
Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis Patients, Single-Center, Prospective, Open-Label, Single-Arm Clinical Trial, Long-Term Follow-up.
Clinical Trial with a reported sample of 17 on Neuroinflammation, published in Cell J (2021) — summary generated from the PubMed abstract.
- 2021
- n = 17
Cell J7 citations - Level CProspective StudyPubMed
Intralesional allogeneic adipose-derived stem cells application in chronic diabetic foot ulcer: Phase I/2 safety study.
Prospective Study with a reported sample of 10 on Diabetic Foot, Chronic Wound, published in Foot Ankle Surg (2020) — summary generated from the PubMed abstract.
- 2020
- n = 10
Foot Ankle Surg51 citations - Level CProspective StudyPubMed
A Regenerative Approach to Canine Osteoarthritis Using Allogeneic, Adipose-Derived Mesenchymal Stem Cells. Safety Results of a Long-Term Follow-Up.
Prospective Study on Osteoarthritis, Ankle Injury, published in Front Vet Sci (2020) — summary generated from the PubMed abstract.
- 2020
Front Vet Sci15 citations - Level ARandomized Controlled TrialPubMed
A phase Ib/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacteria
Randomized Controlled Trial with a reported sample of 180 on Systemic / IV, published in BMC Pulm Med (2020) — summary generated from the PubMed abstract.
- 2020
- n = 180
BMC Pulm Med11 citations - Level BClinical TrialPubMed
Allogeneic Adipose-Derived Mesenchymal Stem Cells (Horse Allo 20) for the Treatment of Osteoarthritis-Associated Lameness in Horses: Characterization, Safety, and Efficacy of Intra-Articular Treatment.
Clinical Trial with a reported sample of 80 on Osteoarthritis, Chronic Inflammation, published in Stem Cells Dev (2018) — summary generated from the PubMed abstract.
- 2018
- n = 80
Stem Cells Dev26 citations - Level BClinical TrialPubMed
Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safety.
Clinical Trial on Immune Modulation, Autoimmune Research, published in Vet Rec (2018) — summary generated from the PubMed abstract.
- 2018
Vet Rec - Level DLaboratory StudyPubMed
Safety of Allogeneic Canine Adipose Tissue-Derived Mesenchymal Stem Cell Intraspinal Transplantation in Dogs with Chronic Spinal Cord Injury.
Laboratory Study on Spinal Cord Injury, published in Stem Cells Int (2017) — summary generated from the PubMed abstract.
- 2017
Stem Cells Int - Level BClinical TrialPubMed
Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety Study.
Clinical Trial on Cardiovascular Disease, published in Stem Cells Transl Med (2017) — summary generated from the PubMed abstract.
- 2017
Stem Cells Transl Med95 citations - Level BClinical TrialPubMed
Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Clinical and laboratory outcomes.
Clinical Trial on Autoimmune Research, published in Vet J (2015) — summary generated from the PubMed abstract.
- 2015
Vet J - Level BRandomized Controlled TrialPubMed
Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
Randomized Controlled Trial on Stroke Research, published in J Stroke Cerebrovasc Dis (2014) — summary generated from the PubMed abstract.
- 2014
J Stroke Cerebrovasc Dis - Level DAnimal StudyPubMed
Safety and immunomodulatory effects of allogeneic canine adipose-derived mesenchymal stromal cells transplanted into the region of the lacrimal gland, the gland of the third eyelid and the knee joint.
Animal Study on Osteoarthritis, Immune Modulation, published in Cytotherapy (2013) — summary generated from the PubMed abstract.
- 2013
Cytotherapy40 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406